Works matching IS 20050380 AND DT 2019 AND VI 30 AND IP 6
Results: 26
The power of the Risk of Ovarian Malignancy Algorithm considering menopausal status: a comparison with CA 125 and HE4.
- Published in:
- Journal of Gynecologic Oncology, 2019, v. 30, n. 6, p. 1, doi. 10.3802/jgo.2019.30.e83
- By:
- Publication type:
- Article
Long-term outcomes of progestinplus metformin as a fertility-sparing treatment for atypical endometrial hyperplasia and endometrial cancer patients.
- Published in:
- Journal of Gynecologic Oncology, 2019, v. 30, n. 6, p. 1, doi. 10.3802/jgo.2019.30.e90
- By:
- Publication type:
- Article
Comments on: Pharmacokinetics of cisplatin during open and minimallyinvasive secondary cytoreductive surgery plus HIPEC in women with platinum-sensitive recurrent ovarian cancer: a prospective study.
- Published in:
- Journal of Gynecologic Oncology, 2019, v. 30, n. 6, p. 1, doi. 10.3802/jgo.2019.30.e111
- By:
- Publication type:
- Article
The 61st Annual Meeting of the Japanese Society for Gynecologic Oncology (JSGO).
- Published in:
- Journal of Gynecologic Oncology, 2019, v. 30, n. 6, p. 1, doi. 10.3802/jgo.2019.30.e114
- By:
- Publication type:
- Article
Investigating the role of immunotherapy in advanced/ recurrent female genital tract melanoma: a preliminary experience.
- Published in:
- Journal of Gynecologic Oncology, 2019, v. 30, n. 6, p. 1, doi. 10.3802/jgo.2019.30.e94
- By:
- Publication type:
- Article
Principal Editor manual of Editorial Manager.
- Published in:
- Journal of Gynecologic Oncology, 2019, v. 30, n. 6, p. 1
- Publication type:
- Article
The efficacy of secondary cytoreductive surgery for recurrent ovarian, tubal, or peritoneal cancer in Tian-model low-risk patients.
- Published in:
- Journal of Gynecologic Oncology, 2019, v. 30, n. 6, p. 1, doi. 10.3802/jgo.2019.30.e100
- By:
- Publication type:
- Article
Associate Editor manual of Editorial Manager.
- Published in:
- Journal of Gynecologic Oncology, 2019, v. 30, n. 6, p. 1
- Publication type:
- Article
Prognostic factors and effects of fertility-sparing surgery in women of reproductive age with ovarian clearcell carcinoma: a propensity scor analysis.
- Published in:
- Journal of Gynecologic Oncology, 2019, v. 30, n. 6, p. 1, doi. 10.3802/jgo.2019.30.e102
- By:
- Publication type:
- Article
Fertility sparing treatment for early stage endometrial cancer: current situation and new strategy.
- Published in:
- Journal of Gynecologic Oncology, 2019, v. 30, n. 6, p. 1, doi. 10.3802/jgo.2019.30.e117
- By:
- Publication type:
- Article
ASGO, KSGO, and JSGO announce collaboration.
- Published in:
- Journal of Gynecologic Oncology, 2019, v. 30, n. 6, p. 1, doi. 10.3802/jgo.2019.30.e115
- Publication type:
- Article
Evaluation of non-completion of intraperitoneal chemotherapy in patients with advanced epithelial ovarian cancer.
- Published in:
- Journal of Gynecologic Oncology, 2019, v. 30, n. 6, p. 1, doi. 10.3802/jgo.2019.30.e93
- By:
- Publication type:
- Article
Reviewer recognition in 2019.
- Published in:
- Journal of Gynecologic Oncology, 2019, v. 30, n. 6, p. 1, doi. 10.3802/jgo.2019.30.e110
- Publication type:
- Article
Relationship between the precursors of high grade serous ovarian cancer and patient characteristics: decreased incidence of the p53 signature in pregnant women.
- Published in:
- Journal of Gynecologic Oncology, 2019, v. 30, n. 6, p. 1, doi. 10.3802/jgo.2019.30.e96
- By:
- Publication type:
- Article
GUIDE TO REVIEWING A MANUSCRIPT.
- Published in:
- Journal of Gynecologic Oncology, 2019, v. 30, n. 6, p. 1
- Publication type:
- Article
Concurrence of ovarian cancer and dermatomyositis: a propensity score analysis.
- Published in:
- Journal of Gynecologic Oncology, 2019, v. 30, n. 6, p. 1, doi. 10.3802/jgo.2019.30.e99
- By:
- Publication type:
- Article
Neoadjuvant chemotherapy for epithelial ovarian cancer in Japan: a JSGO-JSOG joint study.
- Published in:
- Journal of Gynecologic Oncology, 2019, v. 30, n. 6, p. 1, doi. 10.3802/jgo.2019.30.e113
- By:
- Publication type:
- Article
Accuracy of frozen section diagnosis and factors associated with final pathological diagnosis upgrade of mucinous ovarian tumors.
- Published in:
- Journal of Gynecologic Oncology, 2019, v. 30, n. 6, p. 1, doi. 10.3802/jgo.2019.30.e95
- By:
- Publication type:
- Article
Therapeutic vaccination using HPV 16 E7 to eradicate CIN3.
- Published in:
- Journal of Gynecologic Oncology, 2019, v. 30, n. 6, p. 1, doi. 10.3802/jgo.2019.30.e119
- By:
- Publication type:
- Article
A phase 1/2a, dose-escalation, safety and preliminary efficacy study of oral therapeutic vaccine in subjects with cervical intraepithelial neoplasia 3.
- Published in:
- Journal of Gynecologic Oncology, 2019, v. 30, n. 6, p. 1, doi. 10.3802/jgo.2019.30.e88
- By:
- Publication type:
- Article
Prognostic value of neutrophil-tolymphocyte ratio in early-stage ovarian clear-cell carcinoma.
- Published in:
- Journal of Gynecologic Oncology, 2019, v. 30, n. 6, p. 1, doi. 10.3802/jgo.2019.30.e85
- By:
- Publication type:
- Article
Prognostic value of metabolic tumor volume and total lesion glycolysis from 18F-FDG PET/CT in lymph node metastases and risk stratification of endometrial carcinoma.
- Published in:
- Journal of Gynecologic Oncology, 2019, v. 30, n. 6, p. 1, doi. 10.3802/jgo.2019.30.e89
- By:
- Publication type:
- Article
The Annual Meeting of the Thai Gynecologic Cancer Society 2019: Meeting report.
- Published in:
- Journal of Gynecologic Oncology, 2019, v. 30, n. 6, p. 1, doi. 10.3802/jgo.2019.30.e118
- By:
- Publication type:
- Article
Clinicopathologic features, treatment, prognosis and prognostic factors of neuroendocrine carcinoma of the endometrium: a retrospective analysis of 42 cases from the Kansai Clinical Oncology Group/Intergroup study in Japan.
- Published in:
- Journal of Gynecologic Oncology, 2019, v. 30, n. 6, p. 1, doi. 10.3802/jgo.2019.30.e103
- By:
- Publication type:
- Article
Which patients benefit from secondary cytoreductive surgery in recurrent ovarian cancer?
- Published in:
- Journal of Gynecologic Oncology, 2019, v. 30, n. 6, p. 1, doi. 10.3802/jgo.2019.30.e116
- By:
- Publication type:
- Article
A phase II study of neoadjuvant chemotherapy plus durvalumab and tremelimumab in advanced-stage ovarian cancer: a Korean Gynecologic Oncology Group Study (KGOG 3046), TRU-D.
- Published in:
- Journal of Gynecologic Oncology, 2019, v. 30, n. 6, p. 1, doi. 10.3802/jgo.2019.30.e112
- By:
- Publication type:
- Article